Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,623 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,623 in last 12 months

Showing 78217840 of 13,380 recalls

DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL from Stock...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 25 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 100 mg in 0.9% Sodium Chloride 250 mL Bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mL Recalled...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: EPINEPHrine HCl 4 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q4 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Chlorhexidine Gluconate Oral Rinse Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q2 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Pfizer Inc.

Recalled Item: Deferoxamine Mesylate for injection Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm failed to control impurity for color change at the API...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 11, 2017· Dr. Reddy's Laboratories, Inc.

Recalled Item: Pravastatin Sodium Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: high out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 6, 2017· Hospira Inc., A Pfizer Company

Recalled Item: Argatroban Injection Recalled by Hospira Inc., A Pfizer Company Due to...

The Issue: Failed Impurities/Degradation Specifications; out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 6, 2017· Baxter Healthcare Corporation

Recalled Item: 5% Dextrose Injection Recalled by Baxter Healthcare Corporation Due to Lack...

The Issue: Lack of Assurance of Sterility: Bags have the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 6, 2017· Baxter Healthcare Corporation

Recalled Item: 0.9% Sodium Chloride Injection USP Recalled by Baxter Healthcare Corporation...

The Issue: Lack of Assurance of Sterility: Customer complaints for leaking bags.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 6, 2017· Baxter Healthcare Corporation

Recalled Item: 0.9% Sodium Chloride Injection Recalled by Baxter Healthcare Corporation Due...

The Issue: Lack of Assurance of Sterility: Bags have the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 5, 2017· HARDCORE FORMULATIONS

Recalled Item: ULTRA-STEN Rapid Size and Strength capsules Recalled by HARDCORE...

The Issue: Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJuly 5, 2017· Precision Dose Inc.

Recalled Item: Carbamazepine Oral Suspension Recalled by Precision Dose Inc. Due to...

The Issue: Labeling Error: Label mix-up. Products' unit dose cups are correctly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 5, 2017· HARDCORE FORMULATIONS

Recalled Item: D-ZINE Rapid Size and Strength capsules Recalled by HARDCORE FORMULATIONS...

The Issue: Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJune 29, 2017· Teva Pharmaceuticals USA

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per...

The Issue: Failed Impurities/Degradation Specifications: out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 29, 2017· Teva Pharmaceuticals USA

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets Recalled by Teva...

The Issue: Failed Impurities/Degradation Specifications: out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund